Steady-State

Understanding Steady-State

Steady-state represents a dynamic equilibrium in drug therapy. Rather than a single fixed concentration, it describes a stable pattern where drug levels fluctuate predictably between doses but average the same from one dosing interval to the next.

Concept	Before Steady-State	At Steady-State
Drug accumulation	Increasing each dose	No further accumulation
Average concentration	Rising	Constant
Peak-trough pattern	Changing	Repeatable
Elimination rate	Less than input	Equals input

Time to Reach Steady-State

The time required to reach steady-state depends almost entirely on half-life:

The 4-5 Half-Life Rule

Steady-state is approximately achieved after 4-5 elimination half-lives:

Half-Lives Elapsed	% of Steady-State
1 half-life	50%
2 half-lives	75%
3 half-lives	87.5%
4 half-lives	93.75%
5 half-lives	96.875%

Practical Examples

Drug	Half-Life	Time to Steady-State
Native GLP-1	~2 minutes	~10 minutes
Liraglutide	~13 hours	~2-3 days
Semaglutide	~7 days	~4-5 weeks

Clinical Implications

Dosing Decisions

Understanding steady-state timing affects clinical management:

• Efficacy assessment should wait until steady-state
• Dose adjustments need time to show full effect
• Side effect patterns may change as levels accumulate

Titration Protocols

Many peptides use gradual dose increases:

Semaglutide example:

• Week 1-4: 0.25mg (building toward steady-state)
• Week 5-8: 0.5mg (new steady-state in ~5 weeks)
• Further increases: Each requires ~5 weeks to stabilize

Steady-State Parameters

At steady-state, several parameters become clinically meaningful:

Parameter	Symbol	Description
Average concentration	Css,avg	Mean level over dosing interval
Maximum concentration	Css,max	Peak at steady-state
Minimum concentration	Css,min	Trough at steady-state
Fluctuation	%	Degree of peak-trough variation

Calculating Accumulation

The accumulation factor predicts how much higher steady-state levels will be compared to single-dose levels:

For drugs given at intervals equal to the half-life, steady-state concentrations are approximately 2x single-dose levels.

Factors Affecting Steady-State

Drug-Related Factors

• Half-life - Longer half-life = longer time to steady-state
• Dosing interval - Affects fluctuation pattern
• Dose size - Determines absolute concentration levels

Patient-Related Factors

• Renal function - Affects elimination, thus accumulation
• Hepatic function - May alter metabolism and clearance
• Age - Can affect both metabolism and clearance
• Body composition - Influences volume of distribution

Steady-State in Peptide Therapy

Long-Acting GLP-1 Agonists

Weekly semaglutide reaches steady-state after approximately 4-5 weeks of consistent dosing. This explains why:

• Full therapeutic effect takes weeks to manifest
• Dose titration intervals span several weeks
• Side effects may evolve as levels accumulate

Growth Hormone Secretagogues

Shorter half-life peptides reach steady-state faster but show more fluctuation between doses.

Frequently Asked Questions

Why does it take so long for weekly semaglutide to reach full effect?

With a 7-day half-life, semaglutide requires 4-5 half-lives (4-5 weeks) to approach steady-state. During this time, each weekly dose adds to the residual from previous doses until accumulation stabilizes.

Can I speed up reaching steady-state with a loading dose?

Yes, a loading dose (higher initial dose) can achieve target concentrations faster. However, this approach isn’t commonly used with GLP-1 agonists because rapid accumulation increases gastrointestinal side effects.

Does steady-state mean my blood levels are constant?

No. Even at steady-state, concentrations rise after dosing and fall before the next dose. What becomes constant is the pattern - the same peak, the same trough, the same average, repeating with each dosing cycle.